ArticleBreast cancer research : BCR2025

Evaluating risk factors for Trastuzumab-Deruxtecan Pneumonitis in patients with metastatic breast cancer.

Jonathan Henricks et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.